Ventricular Assist Devices (VADs) Market in Asia Pacific is expected to register a CAGR of 12.4% during the forecast period (2018 - 2024) - KBV Research

According to a new report Asia Pacific Ventricular Assist Devices (VADs) Market, published by KBV research, the Asia Pacific Ventricular Assist Devices (VADs) Market would witness market growth of 12.4% CAGR during the forecast period (2018 – 2024).

The Japan market would dominate the Asia Pacific Right Ventricular Assist Devices (LVADs) Market by Country 2024; growing at a CAGR of 9.4 % during the forecast period. The China market is expected to witness a CAGR of 12.4% during (2018 - 2024). Additionally, the India market is expected to witness a CAGR of 13% during (2018 - 2024).

The Bridge-to-transplant (BTT) Therapy market dominated the Asia Pacific Ventricular Assist Devices Market by Application 2017, thereby, achieving a market value of $190.5 million by 2024, The Destination Therapy market is expected to witness a CAGR of 12.1% during (2018 - 2024). The Bridge-to-recovery (BTR) Therapy market is expected to witness a CAGR of 13.8% during (2018 - 2024). Additionally, the Bridge-to-candidacy (BTC) Therapy market is expected to witness highest CAGR of 14.5% during (2018 - 2024).

The Implantable Ventricular Assist Devices market dominated the India Ventricular Assist Devices Market by Design 2017,; thereby, achieving a market value of $59.9 million by 2024,. The Transcutaneous Ventricular Assist Devices market is expected to witness a CAGR of 14.3% during (2018 - 2024).

Full Report: https://www.kbvresearch.com/asia-pacific-ventricular-assist-devices-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Berlin Heart GmbH, Cardiac Assist, Inc. ( LivaNova), HeartWare International, Inc., Jarvik Heart, Inc., Reliant Heart, Inc., Abbott, Sun Medical Technology Research Corp., Syncardia System, Inc., Thoratec Corporation and Abiomed

Asia Pacific Ventricular Assist Devices (VADs) Market Segmentation

By Product

• Left Ventricular Assist Devices (LVADs)
• Right Ventricular Assist Devices (RVADs)
• Biventricular Assist Devices (BIVADs)

By Design

• Implantable Ventricular Assist Devices
• Transcutaneous Ventricular Assist Devices

By Application

• Bridge-to-transplant (BTT) Therapy
• Destination Therapy
• Bridge-to-recovery (BTR) Therapy
• Bridge-to-candidacy (BTC) Therapy

 By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Companies Profiled

• Berlin Heart GmbH,
• Cardiac Assist, Inc. ( LivaNova)
• HeartWare International, Inc.
• Jarvik Heart, Inc.
• Reliant Heart, Inc.
• Abbott
•  Sun Medical Technology Research Corp.
• Syncardia System, Inc.
• Thoratec Corporation
• Abiomed

Unique Offerings from KBV Research

• Exhaustive coverage  
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Related Reports:

Global Ventricular Assist Devices Market

North America Ventricular Assist Devices Market

Europe  Ventricular Assist Devices Market

LAMEA Ventricular Assist Devices Market